Total Visits
Views | |
---|---|
Long-Term ... | 44 |
Total Visits Per Month
October 2023 | November 2023 | December 2023 | January 2024 | February 2024 | March 2024 | April 2024 | |
---|---|---|---|---|---|---|---|
Long-Term ... | 0 | 0 | 0 | 4 | 0 | 2 | 3 |
File Visits
Views | |
---|---|
long_term_efficacy_safety_long_acting_complement_c5_inhibitor_ravulizumab_treatment_atypical_hemolytic_uremic_syndrome_adults_2021.pdf | 13 |
long_term_efficacy_safety_long_acting_complement_c5_inhibitor_ravulizumab_treatment_atypical_hemolytic_uremic_syndrome_adults_2021_material_suplementari.pdf | 6 |
Top country views
Views | |
---|---|
United States | 31 |
Spain | 4 |
Sweden | 3 |
Germany | 2 |
Slovenia | 2 |
Belgium | 1 |
France | 1 |
Top cities views
Views | |
---|---|
Chandler | 11 |
Barcelona | 4 |
Ashburn | 3 |
Koper | 2 |
Stockholm | 2 |
Boardman | 1 |
Brussels | 1 |
Buffalo | 1 |
Karlsruhe | 1 |
Phoenix | 1 |